Top Markets
Coin of the day
Diagnocure, Inc. Diagnocure, Inc.

Diagnocure, Inc.

DGCRF
Rangering i aksjer #41418
Diagnocure, Inc. is a Canadian life sciences company dedicated to developing... Diagnocure, Inc. is a Canadian life sciences company dedicated to developing and commercializing innovative products for cancer diagnosis. Its core business revolves around advanced molecular diagnostic tests designed for the identification and management of cancerous conditions. The company's portfolio includes the PCA3 test for prostate cancer diagnosis, as well as the Guanylyl Cyclase C (GCC) marker and the Previstage GCC colorectal cancer staging test, both vital for patients with colorectal cancer. They also offer PCP, a multi-marker diagnostic for prostate cancer. In addition to these tests, Diagnocure provides specialized services such as gene expression and copy number variation analysis, mutation detection, SNP genotyping, and comprehensive platform and laboratory environmental support. Established in 1994 as 9342-8530 Québec Inc. and previously known as DiagnoCure Inc., the company is headquartered in Quebec, Canada.
Aksjekurs
$0.0001
Sist synkronisert: 2025-06-11
Markedsverdi
$21.52K
Endring (1 dag)
0.00%
Endring (1 år)
0.00%
Land
CA
Handel Diagnocure, Inc. (DGCRF)

Kategori

Aksjeprishistorikk for Diagnocure, Inc. (DGCRF)
Høyeste sluttskurs: $0.00 den 2025-06-01

Laveste sluttskurs: $0.77 den 2012-06-01
Aksjeprishistorikk for Diagnocure, Inc. fra 2012 til 2026
Årlig aksjeprisytelse
År Ytelse
2025 0.00%
2024 9,900.00%
2022 -99.50%
2021 100.00%
2020 -50.00%
2019 -77.65%
2018 -14.62%
2017 -7.14%
2016 -98.56%
2015 -20.88%
2014 -39.86%
2013 -53.79%
2012 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
$236.22 -4.39%
IE
$15.84 -13.29%
CN
$532.45 10.93%
CH
$171.67 -9.77%
CH
$2.37 -28.64%
CN